mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.05 |
mRNA |
lapatinib |
gCSI |
pan-cancer |
AAC |
-0.11 |
0.05 |
mRNA |
KIN001-266 |
GDSC1000 |
pan-cancer |
AAC |
0.066 |
0.05 |
mRNA |
WZ-1-84 |
GDSC1000 |
pan-cancer |
AAC |
0.099 |
0.05 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.05 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.05 |
mRNA |
PD-0325901 |
CCLE |
pan-cancer |
AAC |
-0.082 |
0.05 |
mRNA |
BRD-K99006945 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.06 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.06 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.06 |